Compare Ferguson Enterprises Inc. Common Stock (FERG) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ferguson Enterprises Inc. Common Stock vs Inovio Pharmaceuticals Inc — how do they compare? Ferguson Enterprises Inc. Common Stock trades at $222 (market cap $43.11B), while Inovio Pharmaceuticals Inc trades at $1.18 (market cap $103.19M). The key difference: Ferguson Enterprises Inc. Common Stock is far larger — about 417.8× Inovio Pharmaceuticals Inc's market cap, and Ferguson Enterprises Inc. Common Stock pays a 1.6% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ferguson Enterprises Inc. Common Stock for 0 Days and Inovio Pharmaceuticals Inc for 43 Days on average.
| FERG | INO | |
|---|---|---|
Market Cap | $43.11B | $103.19M |
Volume | 945,793 | 8,461,580 |
Sector | Industrials | Health |
52-Week High | $267.71 | $2.60 |
52-Week Low | $214.26 | $0.66 |
Typical Hold Time | 0 Days | 43 Days |
Enterprise Value | $49.56B | $74.52M |
Dividend Yield | 1.6% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Inovio Pharmaceuticals (INO) trades at $0.9982, down 9.67% in the last session, with a bearish technical signal and negative financial metrics including a net income margin of -130,000%. The company shows consistent quarterly earnings beats but faces significant cash burn, with operating cash flow negative at -$88.63M in 2025. Key near-term catalyst is the FDA decision on INO-3107 expected by October 30, 2026.
INO presents high-risk speculative opportunity with analyst consensus price target of $2.75 representing 175% upside potential. The investment case hinges on successful FDA approval and commercialization of INO-3107, but carries substantial risk from persistent losses, negative cash flow, and dependence on financing activities to sustain operations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ferguson Enterprises Inc. Common Stock
Ferguson Enterprises, Inc. distributes plumbing, HVAC, waterworks, and related building products to professional contractors, builders, and facility managers across North America, operating through branches, showrooms, and digital commerce.
Read more on FERG →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
